subject: Aarkstore Enterprise -- Migraine - Pipeline Assessment And Market Forecasts To 2016 [print this page] Aarkstore announce a new report "Migraine - Pipeline Assessment and Market Forecasts to 2016" through its vast collection of market research report.
Summary
The industry analysis specialists new report, Migraine - Pipeline Assessment and Market Forecasts to 2016 is an essential source of information and analysis on the global migraine market. The report identifies the key trends shaping and driving the global migraine market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global migraine sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis team of industry experts.
Scope
The report provides information on the key driver and challenges of the global migraine market. Its scope includes:
- Annualized global migraine market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include 5-HT1D agonist, 5-HT1 agonist, AMPA/kainate receptor antagonist, Neuro transmitter system receptor, bacterial Neurotoxin (muscle relaxant), 5-HT targetor, calcitonin gene related peptide (CGRP) targetors, GABA transaminase inhibitors, nitric oxide inhibitors, prostaglandin synthesis inhibitor, opioid receptor agonist, antiemetic and gastroprokinetic agents, anti-inflammatory and immunosuppressant, and cyclooxygenase-2 (COX-2) inhibitors.
- Analysis of the current and future market competition in the global migraine market. Key market players covered are GlaxoSmithKline, Eli Lilly and Company, Merck & Co., Inc., Pozen, Inc., Eisai Co., Ltd., Johnson & Johnson, Inc., NuPathe Inc., and Abbott Laboratories.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the future market associated with migraine therapeutics.
